Using Serum Advanced Glycation End Products-Peptides to Improve the Efficacy of World Health Organization Fasting Plasma Glucose Criterion in Screening for Diabetes in High-Risk Chinese Subjects

The efficacy of using fasting plasma glucose (FPG) alone as a preferred screening test for diabetes has been questioned. This study was aimed to evaluate whether the use of serum advanced glycation end products-peptides (sAGEP) would help to improve the efficacy of FPG in diabetes screening among hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Zilin, He, Jiajia, Qiu, Shanhu, Lei, Chenghao, Zhou, Yi, Xie, Zuolin, Zhang, Lin, Wang, Yanping, Jin, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569373/
https://www.ncbi.nlm.nih.gov/pubmed/26368827
http://dx.doi.org/10.1371/journal.pone.0137756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569373/
https://www.ncbi.nlm.nih.gov/pubmed/26368827
http://dx.doi.org/10.1371/journal.pone.0137756

Ejemplares similares